A UK biotech start-up has secured $14mn in early-stage funding led by MSD Global Health Innovation Fund to develop vaccines that are “future-proofed” by artificial intelligence.
Baseimmune uses AI to help it predict future pathogen mutations with the goal of creating jabs for coronavirus, malaria and African swine fever that will be more effective for longer.
您已閱讀15%（501字），剩餘85%（2784字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。